logo-loader
viewHalliburton Company

Halliburton reports declining 3Q profit and revenue; shares slip pre-market

It blamed the 32% drop in quarterly profit on weak demand for its services and equipment from oil and gas producers in North America

Halliburton Company - Halliburton Company reported declining profit and revenue in the third quarter on weak demand for its services and equipment from oil and gas producers in North America
Halliburton’s stock has fallen more than 30% this year

Halliburton Company (NYSE:HAL) on Monday reported declining profit and revenue in the third quarter, sending shares down nearly 2% in pre-market trading. 

The company blamed the 32% drop in quarterly profit on weak demand for its services and equipment from oil and gas producers in North America, its biggest market. 

Net profit fell to $295 million, or $0.34 cents per share, in the third quarter ended September 30, from $435 million, or $0.50 cents per share, a year earlier. Analysts had on average estimated $0.34 cents per share earnings.

Reduced spending by oil and gas producers

Revenue fell 10% to $5.55 billion, below analysts’ average estimate of $5.80 billion.

Halliburton and its rivals are battling reduced spending by oil and gas producers as investors push for higher returns rather than growth in a weak oil price environment.

Larger rival Schlumberger Limited (NYSE:SLB) said on Friday it had recorded a $1.58 billion goodwill impairment charge related to its pressure pumping business in North America.

Halliburton’s stock, which has fallen more than 30% this year, recently traded down to $18.16 a share in New York.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

 

Quick facts: Halliburton Company

Price: 21.59 USD

NYSE:HAL
Market: NYSE
Market Cap: $18.97 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

OptiBiotix Health agrees exclusive deal for LPLDL in USA and Canada

Steve Prescott, the chief executive of ProBiotix, which is a wholly-owned subsidiary of OptiBiotix Health PLC (LON:OPTI), caught up for a brief chat with Proactive London's Andrew Scott after announcing they've signed a distributor agreement with Advanced NutriSolutions Inc./Select Ingredient...

15 minutes ago

2 min read